<DOC>
	<DOCNO>NCT00153556</DOCNO>
	<brief_summary>Hib disease rate rural Alaska introduction HIb conjugate vaccine among high world . Since vaccine introduction , rate fall 90 % disease eliminate . This study design test one possible mean eliminate Hib carriage thus eliminate person person transmission invasive disease . The objective study evaluate effectiveness community-wide use Hib conjugate vaccine eliminate oropharyngeal Hib carriage rural Alaska village . Secondary objective include : - Determine risk factor Hib OP carriage include demographic characteristic , immunologic characteristic ( antibody level function ) . This accomplish case-control study describe . - Measure antibody response Hib conjugate vaccine among adult previously receive Hib vaccine . This accomplished cohort study participate adult vaccine intervention community .</brief_summary>
	<brief_title>Study Eliminate Hib Carriage Rural Alaska Native Villages</brief_title>
	<detailed_description>This pilot intervention ass feasibility use Hib conjugate vaccine eliminate Hib carriage rural Alaska village , three village serve comparison group . WE perform community-wide survey Hib carriage recruit volunteer throat culture establish baseline rate Hib carriage community . Then Hib carrier offer chemoprophylaxis clear Hib throat . In vaccine intervention community , single dose Hib conjugate vaccine offer person age . This follow second community-wide Hib carriage survey one year ass effectiveness intervention .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>All village resident eligible Hib colonization survey All resident select village eligible vaccine study except note . For receipt vaccine : history allergic reaction Hib vaccine component Age &lt; 24 month due Hib vaccine accord childhood immunization schedule Age &gt; 24 month receive HIb vaccine within past year Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Haemophilus influenza type B</keyword>
	<keyword>Carrier state</keyword>
	<keyword>Bacterial Vaccines</keyword>
	<keyword>Anti-PRP antibody</keyword>
	<keyword>Antibody avidity</keyword>
	<keyword>Serum bacteriocidal antibody</keyword>
	<keyword>American Indians/Alaska Natives</keyword>
	<keyword>Case control study</keyword>
	<keyword>Adult vaccine</keyword>
</DOC>